Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16680751
[patent_doc_number] => 10940207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Ice-based lipid nanoparticle formulation for delivery of mRNA
[patent_app_type] => utility
[patent_app_number] => 16/773638
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 36159
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16773638
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/773638 | Ice-based lipid nanoparticle formulation for delivery of mRNA | Jan 26, 2020 | Issued |
Array
(
[id] => 18398222
[patent_doc_number] => 11660338
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-30
[patent_title] => Particles comprising a shell with RNA
[patent_app_type] => utility
[patent_app_number] => 16/749012
[patent_app_country] => US
[patent_app_date] => 2020-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 23009
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16749012
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/749012 | Particles comprising a shell with RNA | Jan 21, 2020 | Issued |
Array
(
[id] => 16436113
[patent_doc_number] => 20200353438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => METHOD OF FABRICATING CELL ARRAYS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/738408
[patent_app_country] => US
[patent_app_date] => 2020-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16738408
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/738408 | METHOD OF FABRICATING CELL ARRAYS AND USES THEREOF | Jan 8, 2020 | Abandoned |
Array
(
[id] => 18544215
[patent_doc_number] => 11717547
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Compositions and methods for the treatment of autosomal recessive congenital ichthyosis
[patent_app_type] => utility
[patent_app_number] => 16/734156
[patent_app_country] => US
[patent_app_date] => 2020-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 38
[patent_no_of_words] => 33276
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16734156
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/734156 | Compositions and methods for the treatment of autosomal recessive congenital ichthyosis | Jan 2, 2020 | Issued |
Array
(
[id] => 15863147
[patent_doc_number] => 20200138977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => NUCLEIC ACID-CATIONIC POLYMER COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/732770
[patent_app_country] => US
[patent_app_date] => 2020-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14957
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16732770
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/732770 | NUCLEIC ACID-CATIONIC POLYMER COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | Jan 1, 2020 | Abandoned |
Array
(
[id] => 16090387
[patent_doc_number] => 20200199180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => BRANCHED RECEPTOR BINDING MULTI-SUBUNIT PROTEIN COMPLEXES FOR USE IN BACTERIAL DELIVERY VEHICLES
[patent_app_type] => utility
[patent_app_number] => 16/726033
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32418
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16726033
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/726033 | Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles | Dec 22, 2019 | Issued |
Array
(
[id] => 16296252
[patent_doc_number] => 20200281975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => METHODS AND COMPOSITIONS FOR GENE EDITING IN HEMATOPOIETIC STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 16/721156
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16721156
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/721156 | Methods and compositions for gene editing in hematopoietic stem cells | Dec 18, 2019 | Issued |
Array
(
[id] => 17460334
[patent_doc_number] => 20220073639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and Leukemias
[patent_app_type] => utility
[patent_app_number] => 17/416365
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25176
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416365
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/416365 | Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against T cell lymphomas and leukemias | Dec 18, 2019 | Issued |
Array
(
[id] => 16157163
[patent_doc_number] => 20200216814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 16/715859
[patent_app_country] => US
[patent_app_date] => 2019-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16715859
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/715859 | Platform for generating safe cell therapeutics | Dec 15, 2019 | Issued |
Array
(
[id] => 18399317
[patent_doc_number] => 11661443
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-30
[patent_title] => Chimeric receptor binding proteins for use in bacterial delivery vehicles
[patent_app_type] => utility
[patent_app_number] => 16/696769
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 30787
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16696769
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/696769 | Chimeric receptor binding proteins for use in bacterial delivery vehicles | Nov 25, 2019 | Issued |
Array
(
[id] => 15646887
[patent_doc_number] => 20200085973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/681565
[patent_app_country] => US
[patent_app_date] => 2019-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16681565
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/681565 | LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY | Nov 11, 2019 | Abandoned |
Array
(
[id] => 15866841
[patent_doc_number] => 20200140824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => ENHANCED SYSTEMS FOR CELL-MEDIATED ONCOLYTIC VIRAL THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/676413
[patent_app_country] => US
[patent_app_date] => 2019-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16676413
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/676413 | Enhanced systems for cell-mediated oncolytic viral therapy | Nov 5, 2019 | Issued |
Array
(
[id] => 15866909
[patent_doc_number] => 20200140858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => GENE CORRECTION OF POMPE DISEASE AND OTHER AUTOSOMAL RECESSIVE DISORDERS VIA RNA-GUIDED NUCLEASES
[patent_app_type] => utility
[patent_app_number] => 16/674448
[patent_app_country] => US
[patent_app_date] => 2019-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16674448
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/674448 | Gene correction of Pompe disease and other autosomal recessive disorders via RNA-guided nucleases | Nov 4, 2019 | Issued |
Array
(
[id] => 17299939
[patent_doc_number] => 20210395778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => A CODON OPTIMIZED OTOFERLIN AAV DUAL VECTOR GENE THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/290082
[patent_app_country] => US
[patent_app_date] => 2019-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17290082
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/290082 | A CODON OPTIMIZED OTOFERLIN AAV DUAL VECTOR GENE THERAPY | Oct 31, 2019 | Pending |
Array
(
[id] => 16452885
[patent_doc_number] => 20200362311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => RECOMBINANT ADIPOSE-DERIVED STEM CELL AND RECOMBINANT METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/668065
[patent_app_country] => US
[patent_app_date] => 2019-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16668065
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/668065 | Recombinant adipose-derived stem cell and recombinant method thereof | Oct 29, 2019 | Issued |
Array
(
[id] => 18101248
[patent_doc_number] => 11541119
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Tumor treatment methods using cells that localize to the tumor
[patent_app_type] => utility
[patent_app_number] => 16/659986
[patent_app_country] => US
[patent_app_date] => 2019-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 27772
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16659986
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/659986 | Tumor treatment methods using cells that localize to the tumor | Oct 21, 2019 | Issued |
Array
(
[id] => 19181220
[patent_doc_number] => 11987803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-21
[patent_title] => Efficient delivery of large cargos into cells on a porous substrate
[patent_app_type] => utility
[patent_app_number] => 16/601513
[patent_app_country] => US
[patent_app_date] => 2019-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 8760
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16601513
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/601513 | Efficient delivery of large cargos into cells on a porous substrate | Oct 13, 2019 | Issued |
Array
(
[id] => 15451383
[patent_doc_number] => 20200038515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => ICE-BASED LIPID NANOPARTICLE FORMULATION FOR DELIVERY OF MRNA
[patent_app_type] => utility
[patent_app_number] => 16/599928
[patent_app_country] => US
[patent_app_date] => 2019-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16599928
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/599928 | Ice-based lipid nanoparticle formulation for delivery of mRNA | Oct 10, 2019 | Issued |
Array
(
[id] => 18116357
[patent_doc_number] => 11547729
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-10
[patent_title] => Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases
[patent_app_type] => utility
[patent_app_number] => 16/600268
[patent_app_country] => US
[patent_app_date] => 2019-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 40
[patent_no_of_words] => 21868
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16600268
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/600268 | Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases | Oct 10, 2019 | Issued |
Array
(
[id] => 15740955
[patent_doc_number] => 20200109365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => METHODS OF MAKING T CELL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/597471
[patent_app_country] => US
[patent_app_date] => 2019-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16597471
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/597471 | Methods of making T cell compositions | Oct 8, 2019 | Issued |